SETD5 haploinsufficiency affects mitochondrial compartment in neural cells.

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Neurodevelopmental disorders (NDDs) are complex conditions linked to molecular and cellular dysfunctions.
• SETD5 haploinsufficiency is associated with NDDs, potentially due to chromatin defects.
• Mitochondrial dysfunction is increasingly recognized in NDD patients.

Purpose of the Study:

• To investigate the impact of SETD5 deficiency on neural stem cells and the brain.
• To analyze the transcriptome, mitochondrial structure, dynamics, and function in a Setd5 haploinsufficiency mouse model.
• To explore the interplay between chromatin regulation and mitochondrial function in NDDs.

Main Methods:

• In vitro studies using neural stem cells.
• Analysis of the Setd5 haploinsufficiency mouse model brain.
• Transcriptome interrogation, mitochondrial structure and function analysis.

Main Results:

• SETD5 deficiency leads to transcriptional aberrations that impair mitochondria.
• Reduced SETD5 levels cause mitochondrial fragmentation, decreased membrane potential, and lower ATP production.
• Mitochondria are mislocalized in mutant neurons, with fewer organelles in neurites and synapses.

Conclusions:

• SETD5-associated NDD pathophysiology involves an interplay between chromatin regulation and mitochondrial function.
• Mitochondrial activity and dynamics may serve as novel therapeutic targets for SETD5-loss disorders.
• Further validation in patient contexts is needed to confirm these findings.